The human virus papilloma (HPV) has a primary role in the development of uterine cervix cancer, the second female tumor by world impact. There are several HPV genotypes, some at high risk and others at low risk. With this genetic test, 28 different HPV genotypes are identified, which include both high-risk virotypes and low risk.
The test has a high sensitivity and specificity of reaction, so it leads to a precise and early diagnosis. The test can be carried out on a sample of seminal liquid or on Baslano-Pipuial buffer, anal buffer, vaginal buffer, cervical buffer and urethral buffer and the withdrawal can be carried out externally to the structure. The external sample can be delivered upon compilation of the appropriate form for samples performed externally. Or must be performed on the occasion of the visit with the gynecologist in place for a total cost of € 120. The report will be delivered after 7 days from the acceptance of the sample.